Health

https://www.bbc.com/future/article/20260420-cancer-how-aspirin-may-be-a-powerful-new-weapon-against-tumours
It is not yet clear whether aspirin could protect patients from other cancers as well – but we may soon have some answers. Langley is currently running a large randomised controlled trial with 11,000 participants who've had colorectal, breast, gastroesophageal, or prostate cancer in the UK, Ireland and India. Her team will be looking at the effect of a daily 100mg or 300mg preventative dose of aspirin, and they're hoping to have results next year.

"We really are the first to explore the role of aspirin in other tumour types," she says. She is aiming to replicate Martling's findings for colorectal cancer, as well as gathering funds to investigate the implications of the specific mutations in the other cancers, too. The replication is key, she says, as authorities ideally want two sets of trial results before they make recommendations for patients.
How does it work?